Live Locally, Grow Globally

What's NEW

News & Topics

Tadamitsu Kishimoto to Receive the 2020 Tang Prize


Professor Tadamitsu Kishimoto (Immunology Frontier Research Center, Osaka University) is the recipient of the 2020 Tang Prize for Biopharmaceutical Science.

The Tang Prize was established in 2012 by Dr. Samuel Yin, who is the chairman of the Ruentex Group in Taiwan. The prize includes four independent categories. Up to three recipients are chosen in each category and a total of NT$50 million is awarded per category.

In the 1980s, Professor Kishimoto discovered interleukin 6 (IL-6), which plays important roles in various inflammatory responses such as rheumatoid arthritis and which led to the development of Tocilizumab (commercial name: ActemraR, Chugai Pharmaceutical Co., Ltd.). Actemra is attracting attention as it also may be effective in treating the pneumonia caused by COVID-19.

Professor Kishimoto is commended for his wide-ranging contributions from basic research to clinical medicine. The 2020 Tang Prize is jointly awarded to Prof. Kishimoto and the British and American scientists who discovered inflammatory cytokines and contributed to pharmaceuticals. The award ceremony will be held in Taipei during the Tang Prize week starting in September 2020.

Tang Prize(唐奨)

Kishimoto Lab

Back to top